000 | 01044 a2200313 4500 | ||
---|---|---|---|
005 | 20250512215829.0 | ||
264 | 0 | _c19850114 | |
008 | 198501s 0 0 eng d | ||
022 | _a0009-9228 | ||
024 | 7 |
_a10.1177/000992288402301201 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohnson, J P | |
245 | 0 | 0 |
_aAcquired craniofacial features associated with chronic phenytoin therapy. _h[electronic resource] |
260 |
_bClinical pediatrics _cDec 1984 |
||
300 |
_a671-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
650 | 0 | 4 |
_aFace _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaxillofacial Development _xdrug effects |
650 | 0 | 4 |
_aPhenytoin _xadverse effects |
650 | 0 | 4 |
_aSkull _xdrug effects |
773 | 0 |
_tClinical pediatrics _gvol. 23 _gno. 12 _gp. 671-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/000992288402301201 _zAvailable from publisher's website |
999 |
_c6499222 _d6499222 |